Possible immuno-modulatory effects of tocilizumab in patients with refractory status epilepticus.
Sign Up to like & getrecommendations! Published in 2023 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202302_31392
Abstract: OBJECTIVE Refractory Status Epilepticus (RSE) is a neurologic emergency that carries a high risk of mortality and morbidity. Every year, there are about 200,000 cases in the United States, affecting people of all ages. This… read more here.
Keywords: possible immuno; immuno modulatory; refractory status; status epilepticus ... See more keywords